HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.

Abstract
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
Authors
JournalJournal of toxicology. Clinical toxicology (J Toxicol Clin Toxicol) Vol. 39 Issue 1 Pg. 85-100 ( 2001) ISSN: 0731-3810 [Print] United States
PMID11327233 (Publication Type: Journal Article, Review)
Chemical References
  • Anthrax Vaccines
Topics
  • Adult
  • Animals
  • Anthrax (immunology, prevention & control)
  • Anthrax Vaccines (administration & dosage, adverse effects, therapeutic use)
  • Bacillus anthracis
  • Child
  • Humans
  • Immunity, Cellular
  • Injections, Intramuscular
  • Injections, Subcutaneous
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: